To hear about similar clinical trials, please enter your email below
Trial Title:
Proof-of-concept Study of Blood Markers of Tumor Dissemination in Patients With Versus Without Intestinal Polyps
NCT ID:
NCT05648240
Condition:
Colorectal Cancer
Neoplasm Metastasis
Disseminated Cancer
Conditions: Official terms:
Neoplasm Metastasis
Intestinal Polyps
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Other
Intervention name:
Blood test
Description:
Venous blood samples taken at the moment of colonoscopy to test for biomarkers
Arm group label:
Patients with polyps
Arm group label:
Patients without polyps
Summary:
The study authors hypothesize that in patients with intestinal polyps, tumor cells could
disseminate and circulating factors could be secreted by the polyp. These two parameters
could become biomarkers to refine the follow-up of patients and to establish targeted
therapeutic strategies.
Criteria for eligibility:
Study pop:
Adult patients scheduled for colonoscopy in the Hepato-Gastro-Enterology Department of
the University Hospital of Nîmes. Patients with a family history of colorectal cancer and
aged over 50 years, with a positive Fecal Immunological Test, with bleeding, with
abdominal pain or with unexplained anemia are all likely to undergo colonoscopy
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Patient to be examined by colonoscopy
- The patient must be a member or beneficiary of a health insurance plan
Exclusion Criteria:
- The subject is participating in a category 1 interventional study, or is in a period
of exclusion determined by a previous study
- The subject signals their opposition to participate in the study
- It is impossible to give the subject informed information
- The patient is under safeguard of justice or state guardianship
- Patient pregnant or breastfeeding
- History of proven cancerous disease
- Patient followed for a chronic inflammatory bowel disease
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Locations:
Facility:
Name:
CHU de Nîmes
Address:
City:
Nîmes
Country:
France
Status:
Recruiting
Contact:
Last name:
Anissa Megzari
Phone:
04.66.68.42.36
Email:
drc@chu-nimes.fr
Investigator:
Last name:
Jean-François BOURGAUX
Email:
Principal Investigator
Start date:
February 23, 2023
Completion date:
February 2025
Lead sponsor:
Agency:
Centre Hospitalier Universitaire de Nīmes
Agency class:
Other
Source:
Centre Hospitalier Universitaire de Nīmes
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05648240
